Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Oxypurinol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XORTX Announces Results from Part 2 Pharmacokinetics Bridging Study
    XORTX Announces Results from Part 2 Pharmacokinetics Bridging Study

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502057/0/en/XORTX-Announces-Positive-Topline-Results-from-Part-2-Pharmacokinetics-Bridging-Study.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    XORTX Files FDA Pre-IND Meeting Appeal for XRx-101 (Oxypurinol) COVID-19 Program
    XORTX Files FDA Pre-IND Meeting Appeal for XRx-101 (Oxypurinol) COVID-19 Program

    31 Aug 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/xortx-files-u-s-fda-a-ind-meeting-request-for-xrx-101-oxypurinol-covid-19-program-and-pre-ind-meeting-submissionpotential-of-acute-kidney-injury-emerging-as-a-serious-consequence-of-covid-19/

    BIOSPACE
    31 Aug 2020
    Share Share